Growth Vision

Aramis’ growth strategy is based on a focused commercial approach to maximize the value of its plant-based bioproduction platform in high-potential, high-growth markets. In human health, the company focuses on opportunities where the benefits of production in plants accelerate development, improve manufacturing flexibility, and reduce supply risks. The goal is to build a diversified portfolio of partnerships and commercial programs with recurring revenue prospects and a sustainable presence in international markets.

In animal health, Aramis sees an important opportunity to expand its capabilities to veterinary applications that meet a growing demand for innovative, safe and cost-effective solutions. This diversification allows access to markets with often shorter development cycles and complementary marketing paths to those in the human health sector.

At the same time, Aramis is pursuing a strategy of diversification into specialty ingredients for agriculture, nutrition, cosmetics, industrial applications and research. These segments offer rapid marketing opportunities and make it possible to leverage all of the platform’s capabilities, particularly for the production of proteins, specialized metabolites and other bio-based molecules with high added value. This approach helps reduce dependence on a single market while creating multiple revenue streams.

Aramis’ growth will be supported by the continued expansion of its technology platform, the development of strategic partnerships and a business approach based on agility, speed of execution and rigorous selection of opportunities. By targeting applications where plant bioproduction provides a distinct competitive advantage, the company intends to strengthen its position as a global leader in green biotechnology while generating sustainable economic impact for its partners, customers and the ecosystems it serves.